483
Surmasis Pharmaceutical, LLCSurmasis Pharmaceutical, LLC – FDA 483, Mar 19, 2020
Record Details
An FDA inspection of Sunesis Pharmaceutical in Des Moines, IA, revealed significant deficiencies in the firm's quality control unit and its investigation processes. The company failed to adequately investigate particulate matter in drug products, out-of-specification laboratory results, and numerous environmental monitoring excursions. Additionally, procedures for preventing objectionable microorganisms were found to be inadequate.
View Company Profile
ID · cefb989e-c11c-47e4-a8d6-fed612bc523b
Other documents for Surmasis Pharmaceutical, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.